Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Increlex (Mecasermin [rDNA origin]) Injection
Company:  Tercica, Inc.
Application No.:  021839
Approval Date: 8/30/2005


Date created: October 12, 2005

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.